featured
Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell Lymphomas
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lisocabtagene Maraleucel for Patients With Relapsed or Refractory Large B-Cell Lymphomas (TRANSCEND NHL 001): A Multicentre Seamless Design Study
Lancet 2020 Sep 01;[EPub Ahead of Print], JS Abramson, ML Palomba, LI Gordon, MA Lunning, M Wang, J Arnason, A Mehta, E Purev, DG Maloney, C Andreadis, A Sehgal, SR Solomon, N Ghosh, TM Albertson, J Garcia, A Kostic, M Mallaney, K Ogasawara, K Newhall, Y Kim, D Li, T SiddiqiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.